to PARP or not to PARP....
“EIS-12656 selectively targets tumors with no apparent effects on normal tissues.” ....“Our clinical study will also explore combination therapies that were hindered by combinatorial toxicity in the past.”
EIS-12656, a first-in-class allosteri... - Advanced Prostate...
EIS-12656, a first-in-class allosteric inhibitor of ALC1: will soon start a phase 1 trial
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
Good one… how far out might this one be 5-7 years maybe?
Not what you're looking for?
You may also like...
List of drugs by their metastatic prostate cancer cancer fighting properties
I asked ChatGPT to put the following drugs in order of their metastatic prostate cancer cancer...
trelstar
hi warriors. I have been on trelstar for 8 years and was wondering if anyone else has been on it. I...
Prostrate cell division
Does age effect the speed at which prostate cancer cells divide? There are many factors that affect...
looking for recommendations for top radiation oncologist in Calif or Mayo for second opinions.
My husband had RP in June of 2022 and his PSA started creeping up since September of 2023. His last...
PSA showing .014 - concerned?
I had RP 3/22, PSA went up to .095 3 months after. I started Orgovyx on 8/15/22 had radiation Jan &...
Metastatic Prostate Cancer
Appointment with Provenge doctor
NCT04662580 - All about ARX517 as Monotherapy
primary tumor
Help Understanding My Dad's Biopsy Scores
